A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation.

@article{Obamiro2016ASO,
  title={A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation.},
  author={Kehinde O Obamiro and Leanne Chalmers and Luke Bereznicki},
  journal={American journal of cardiovascular drugs : drugs, devices, and other interventions},
  year={2016},
  volume={16 5},
  pages={349-63}
}
Atrial fibrillation (AF) is a growing public health concern and remains an independent risk factor for ischemic stroke. Warfarin, a commonly used oral anticoagulant, is associated with a 60-70 % relative reduction in stroke risk and a reduction in mortality of 26 %. However, warfarin has several limitations, including a narrow therapeutic window, variable dose response, multiple interactions with other drugs and concurrent illnesses, and the need for frequent laboratory monitoring. In recent… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation.

Journal of the American College of Cardiology • 2017
View 5 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 50 references

Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology • 2016
View 18 Excerpts
Highly Influenced

Adherence to anticoagulant treatment with dabigatran in a real-world setting.

Journal of thrombosis and haemostasis : JTH • 2013
View 3 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…